Skip to content

To Evaluate the Efficacy of Capsimax on Metabolic Rate

A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Efficacy of Capsimax on Metabolic Rate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04025346
Enrollment
44
Registered
2019-07-18
Start date
2019-10-17
Completion date
2020-03-30
Last updated
2020-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism

Brief summary

Capsimax™ is a proprietary Capsicum Extract that employs Beadlet Technology. In the previous study it has been used to investigate its effect in reducing body fat/weight and increase metabolic rate. In this study, Capsimax™ will be used to assess effect on Resting Energy Expenditure (REE) using Indirect Calorimetry.

Interventions

OTHERMicro Crystalline Cellulose

1 capsule to be taken before breakfast.

1 capsule to be taken before breakfast.

Sponsors

Vedic Lifesciences Pvt. Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Double blind, randomized, placebo controlled

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy, adult, male/female participants with age ≥ 18 ≤ 55 years. * A Body Mass Index (BMI) between 18.5 to 29.9 kg/m2. * Fasting blood sugar ≤ 100 mg/dl * Hemoglobin: Males ≥ 11 g/dl and Females ≥ 10 g/dl * BP \< 140/90 mmHg

Exclusion criteria

* Post-menopausal females * History of hypo/ hyperthyroidism. * History of significant neurological or psychiatric condition such as seizures, depression, or insomnia.

Design outcomes

Primary

MeasureTime frameDescription
Effect of Investigational Product on Resting Energy ExpenditureFrom baseline to 4 hours.Assessed by Indirect Calorimetry

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026